185 related articles for article (PubMed ID: 35854065)
1. Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3.
Liu C; Wang J; Zheng Y; Zhu Y; Zhou Z; Liu Z; Lin C; Wan Y; Wen Y; Liu C; Yuan M; Zeng YA; Yan Z; Ge G; Chen J
Oncogene; 2022 Aug; 41(34):4091-4103. PubMed ID: 35854065
[TBL] [Abstract][Full Text] [Related]
2. Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture.
Pan L; Bai P; Weng X; Liu J; Chen Y; Chen S; Ma X; Hu K; Sun A; Ge J
Circulation; 2022 Mar; 145(9):659-674. PubMed ID: 35100526
[TBL] [Abstract][Full Text] [Related]
3. The anticancer properties and mechanism of action of tablysin-15, the RGD-containing disintegrin, in breast cancer cells.
Deng Z; Chai J; Zeng Q; Zhang B; Ye T; Chen X; Xu X
Int J Biol Macromol; 2019 May; 129():1155-1167. PubMed ID: 30660566
[TBL] [Abstract][Full Text] [Related]
4. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
[TBL] [Abstract][Full Text] [Related]
5. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
6. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
7. Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1/STAT1 activation.
Shen L; Kang L; Wang D; Xun J; Chen C; Du L; Zhang M; Gong J; Mi X; Yue S; Zhang Y; Song X; Xiang R; Zhang Z; Tan X
Cancer Lett; 2020 Mar; 472():40-49. PubMed ID: 31857155
[TBL] [Abstract][Full Text] [Related]
8. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
[TBL] [Abstract][Full Text] [Related]
9. Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor Effects.
Liu Y; Goswami RK; Liu C; Sinha SC
Mol Pharm; 2015 Jul; 12(7):2544-50. PubMed ID: 26024761
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an Integrin α
Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
[TBL] [Abstract][Full Text] [Related]
11. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
12. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Targeting Legumain for Inhibiting Cancers.
Reddy BD; Beeraka NM; Chitturi CMK; Madhunapantula SV
Curr Pharm Des; 2021 Oct; 27(31):3337-3348. PubMed ID: 33238867
[TBL] [Abstract][Full Text] [Related]
14. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
[TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells.
Yan T; Zhang A; Shi F; Chang F; Mei J; Liu Y; Zhu Y
J Biol Chem; 2018 Jun; 293(26):10172-10185. PubMed ID: 29752407
[TBL] [Abstract][Full Text] [Related]
16. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
17. Legumain Promotes Gastric Cancer Progression Through Tumor-associated Macrophages
Wang H; Chen B; Lin Y; Zhou Y; Li X
Int J Biol Sci; 2020; 16(1):172-180. PubMed ID: 31892854
[TBL] [Abstract][Full Text] [Related]
18. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
Liu Y; Bajjuri KM; Liu C; Sinha SC
Mol Pharm; 2012 Jan; 9(1):168-75. PubMed ID: 22044266
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
[TBL] [Abstract][Full Text] [Related]
20. Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis.
Zhao T; Liu Y; Hao Y; Zhang W; Tao L; Wang D; Li Y; Liu Z; McKenzie EA; Zhao Q; Diao A
Invest New Drugs; 2021 Apr; 39(2):337-347. PubMed ID: 32978718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]